David Solomon

Plus aucun poste en cours

Profil

David Horn Solomon formerly worked at Silence Therapeutics Plc, as Chief Executive Officer & Director from 2018 to 2020, Zealand Pharma A, as President & Chief Executive Officer from 2009 to 2015, Pharnext SA, as Chief Executive Officer & Director from 2020 to 2022, Bionor Pharma ASA, as President & Chief Executive Officer from 2015 to 2016, Vital Sensors, Inc., as Chief Executive Officer, Akari Therapeutics Plc, as Chief Executive Officer from 2017 to 2018, Mithra Pharmaceuticals SA, as Chief Executive Officer from 2023 to 2024, Promosome LLC, as Executive Chairman from 2016 to 2017, Solomons Ltd., as Chairman, Advicenne SA, as Non-Executive Chairman from 2019 to 2022, Ixaka Ltd., as Chairman, Valerio Therapeutics SA, as Director from 2011 to 2012, Sangamo Therapeutics France SAS, as Independent Director from 2014 to 2018, American Chamber of Commerce In Denmark, as Director, The Cass Foundation, as Director, Silence Therapeutics GmbH, as Managing Director, Critical Care Diagnostics, Inc., as Chief Scientific Officer in 2006, Remedy Pharmaceuticals, Inc., as Chief Scientific Officer in 2006, Vital Sensors Holding Co., Inc., as Chief Operating Officer, Columbia University College of Physicians & Surgeons, as Professor-Pharmacology & Neurology, and Sund Capital ApS, as Managing Partner from 2016 to 2018.
Dr. Solomon received his doctorate degree in 1991 from Weill Cornell Medical College.

Anciens postes connus de David Solomon

Sociétés	Poste	Fin
MITHRA PHARMACEUTICALS S.A.	Directeur Général	05/03/2024
PHARNEXT SCA	Directeur Général	27/11/2022
ADVICENNE	Président	09/06/2022
SILENCE THERAPEUTICS PLC	Directeur Général	01/01/2020
TXCELL	Directeur/Membre du Conseil	01/11/2018

Formation de David Solomon

Weill Cornell Medical College

Doctorate Degree